Abstract
To combat the increasing problem of antibiotic resistance, newer antibiotics have been developed or are under development. This review focuses on the newer antibiotics*, quinupristin-dalfopristin, linezolid, the newer glycopeptides, daptomycin, the cationic peptides and the newer fluoroquinolones. (Rawal Med J 2006;31:85-88)
Key words: Antibiotics, Antibiotic resistance, Antimicrobial cationic peptides, Daptomycin, Linezolid, Quinupristin-dalfopristin
